149 related articles for article (PubMed ID: 28322799)
1. Novel method for measurement of heparin anticoagulant activity using SPR.
Zhao J; Liu X; Malhotra A; Li Q; Zhang F; Linhardt RJ
Anal Biochem; 2017 Jun; 526():39-42. PubMed ID: 28322799
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulant properties of heparin preparations from different animal sources with equivalent high affinity for antithrombin III.
Nagasawa K; Uchiyama H
J Biochem; 1984 Mar; 95(3):619-26. PubMed ID: 6725227
[TBL] [Abstract][Full Text] [Related]
3. Preparation of Low Molecular Weight Heparin from a Remodeled Bovine Intestinal Heparin.
Baytas SN; Varghese SS; Jin W; Yu Y; He P; Douaisi M; Zhang F; Brodfuehrer P; Xia K; Dordick JS; Linhardt RJ
J Med Chem; 2021 Feb; 64(4):2242-2253. PubMed ID: 33586962
[TBL] [Abstract][Full Text] [Related]
4. Chemometric analysis of porcine, bovine and ovine heparins.
Ouyang Y; Han X; Yu Y; Chen J; Fu L; Zhang F; Linhardt RJ; Fareed J; Hoppensteadt D; Jeske W; Kouta A; Zhang Z; Xia K
J Pharm Biomed Anal; 2019 Feb; 164():345-352. PubMed ID: 30428408
[TBL] [Abstract][Full Text] [Related]
5. Structural Analysis of Heparin-Derived 3-O-Sulfated Tetrasaccharides: Antithrombin Binding Site Variants.
Chen Y; Lin L; Agyekum I; Zhang X; St Ange K; Yu Y; Zhang F; Liu J; Amster IJ; Linhardt RJ
J Pharm Sci; 2017 Apr; 106(4):973-981. PubMed ID: 28007564
[TBL] [Abstract][Full Text] [Related]
6. Structural characterization of heparins from different commercial sources.
Zhang F; Yang B; Ly M; Solakyildirim K; Xiao Z; Wang Z; Beaudet JM; Torelli AY; Dordick JS; Linhardt RJ
Anal Bioanal Chem; 2011 Nov; 401(9):2793-803. PubMed ID: 21931955
[TBL] [Abstract][Full Text] [Related]
7. Search for the heparin antithrombin III-binding site precursor.
Linhardt RJ; Wang HM; Loganathan D; Bae JH
J Biol Chem; 1992 Feb; 267(4):2380-7. PubMed ID: 1733939
[TBL] [Abstract][Full Text] [Related]
8. Skeletal muscle myosin and cardiac myosin attenuate heparin's antithrombin-dependent anticoagulant activity.
Morla S; Deguchi H; Griffin JH
J Thromb Haemost; 2021 Feb; 19(2):470-477. PubMed ID: 33176060
[TBL] [Abstract][Full Text] [Related]
9. Analysis of 3-O-sulfo group-containing heparin tetrasaccharides in heparin by liquid chromatography-mass spectrometry.
Li G; Yang B; Li L; Zhang F; Xue C; Linhardt RJ
Anal Biochem; 2014 Jun; 455():3-9. PubMed ID: 24680753
[TBL] [Abstract][Full Text] [Related]
10. Structural characterization of pharmaceutical heparins prepared from different animal tissues.
Fu L; Li G; Yang B; Onishi A; Li L; Sun P; Zhang F; Linhardt RJ
J Pharm Sci; 2013 May; 102(5):1447-57. PubMed ID: 23526651
[TBL] [Abstract][Full Text] [Related]
11. Structure of the antithrombin-binding site in heparin.
Lindahl U; Bäckström G; Höök M; Thunberg L; Fransson LA; Linker A
Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3198-202. PubMed ID: 226960
[TBL] [Abstract][Full Text] [Related]
12. Biological implications of the structural, antithrombin affinity and anticoagulant activity relationships among vertebrate heparins and heparan sulphates.
Hovingh P; Piepkorn M; Linker A
Biochem J; 1986 Jul; 237(2):573-81. PubMed ID: 2948492
[TBL] [Abstract][Full Text] [Related]
13. Antithrombin III affinity dependence on the anticoagulant, antiprotease, and tissue factor pathway inhibitor actions of heparins.
Jeske W; Lormeau JC; Callas D; Iqbal O; Hoppensteadt D; Fareed J
Semin Thromb Hemost; 1995; 21(2):193-200. PubMed ID: 7660142
[TBL] [Abstract][Full Text] [Related]
14. Limitations of conventional anticoagulant therapy and the promises of non-heparin based conformational activators of antithrombin.
Rashid Q; Singh P; Abid M; Jairajpuri MA
J Thromb Thrombolysis; 2012 Aug; 34(2):251-9. PubMed ID: 22453684
[TBL] [Abstract][Full Text] [Related]
15. Fractionation and structural features of two heparin families with high antithrombotic, antilipemic and anticoagulant activities.
Bianchini P; Osima B; Parma B; Nader HB; Dietrich CP; Casu B; Torri G
Arzneimittelforschung; 1985; 35(8):1215-9. PubMed ID: 4074437
[TBL] [Abstract][Full Text] [Related]
16. A sensitive ELISA for the detection of bovine crude heparin in porcine heparin.
Levieux A; Rivera V; Levieux D
J Immunoassay Immunochem; 2001; 22(4):323-36. PubMed ID: 11816801
[TBL] [Abstract][Full Text] [Related]
17. Contribution of chemical 6-O-sulfation of the aminodeoxyhexose residues in whale heparin with high affinity for antithrombin III to its anticoagulant properties.
Uchiyama H; Metori A; Ogamo A; Nagasawa K
J Biochem; 1990 Mar; 107(3):377-80. PubMed ID: 2341372
[TBL] [Abstract][Full Text] [Related]
18. Enzymatic Generation of Highly Anticoagulant Bovine Intestinal Heparin.
Fu L; Li K; Mori D; Hirakane M; Lin L; Grover N; Datta P; Yu Y; Zhao J; Zhang F; Yalcin M; Mousa SA; Dordick JS; Linhardt RJ
J Med Chem; 2017 Oct; 60(20):8673-8679. PubMed ID: 28972371
[TBL] [Abstract][Full Text] [Related]
19. In vivo effects of low molecular weight heparins on experimental thrombosis and bleeding.
Hirsh J
Haemostasis; 1986; 16(2):82-6. PubMed ID: 3710297
[TBL] [Abstract][Full Text] [Related]
20. Chemoenzymatic synthesis of the next generation of ultralow MW heparin therapeutics.
Masuko S; Linhardt RJ
Future Med Chem; 2012 Mar; 4(3):289-96. PubMed ID: 22393937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
